Recent studies show that gastrointestinal hormones, similar to many growth factors, may stimulate cell growth by stimulating intracellular tyrosine phosphorylation signaling cascades. However at present little is known about the ability of these G-protein-coupled receptors to activate these cascades. During the year we have investigated the ability of 4 GI hormones to activate these cascades. In lung cancer cells where PACAP, bombesin-related peptides and neurotensin are known growth factors, we demonstrate each can activate tyrosine kinase cascades with stimulation of tyrosine phosphorylation of p125 focal adhesion kinase, an important cellular mediator of motility and cell attachment. We also demonstrate activation of both the bombesin-related receptor BRS-3 and the PACAP receptor activates the MAP kinase cascade which is an important mediator of cell growth in many cell systems. Furthermore, activation of MAP kinase cascade increases VEGF expression in these cells. In pancreatic acinar cells we have demonstrated activation of the CCKA-R causes rapid tyrosine phosphorylation of p125FAK, paxillin, p130Cas, PYK2 and PKC delta. Our recent studies show PKC delta activation is independent of changes in [Ca2+]i or PI3K but is regulated by activation of PKC-alpha. These studies demonstrate each of these GI hormones/neuropeptides causes activation of tyrosine phosphorylation cascades, and it is likely activation of these cascades is important in mediating many of their growth effects in normal and neoplastic tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK053101-14
Application #
6673787
Study Section
(DDB)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2002
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
González, Nieves; Mantey, Samuel A; Pradhan, Tapas K et al. (2009) Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. Peptides 30:1473-86
Gonzalez, Nieves; Nakagawa, Tomoo; Mantey, Samuel A et al. (2009) Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor. J Pharmacol Exp Ther 331:265-76
Gonzalez, Nieves; Moody, Terry W; Igarashi, Hisato et al. (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15:58-64
Jensen, R T; Battey, J F; Spindel, E R et al. (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42
Gonzalez, Nieves; Hocart, Simon J; Portal-Nunez, Sergio et al. (2008) Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor. J Pharmacol Exp Ther 324:463-74
Berna, Marc J; Jensen, Robert T (2007) Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem 7:1211-31
Moody, Terry W; Mantey, Samuel A; Fuselier, Joseph A et al. (2007) Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Peptides 28:1883-90
Berna, Marc J; Tapia, Jose A; Sancho, Veronica et al. (2007) Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential. Curr Opin Pharmacol 7:583-92
Berna, Marc J; Hoffmann, K Martin; Tapia, Jose A et al. (2007) CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim Biophys Acta 1773:483-501
Corleto, V D; Severi, C; Romano, G et al. (2006) Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil 18:217-25

Showing the most recent 10 out of 27 publications